Status:
WITHDRAWN
Botulinum Toxin Injection With Prostate Brachytherapy
Lead Sponsor:
Emory University
Conditions:
Prostate Cancer
Lower Urinary Tract Symptoms
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to see if botox injection into the prostate during seed implantation (brachytherapy) for prostate cancer a) improves urinary symptoms or avoids need for urinary tract inst...
Detailed Description
Brachytherapy is a popular treatment modality for localized prostate cancer, where radioactive seeds are implanted through 18 gauge needles into the prostate via a perineal template with rectal ultras...
Eligibility Criteria
Inclusion
- Biopsy proven prostate cancer undergoing brachytherapy
Exclusion
- Prior allergic reaction to botulinum toxin
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00681148
End Date
July 1 2012
Last Update
November 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Clinic, Emory University Hospital
Atlanta, Georgia, United States, 30322